Results 71 to 80 of about 8,310 (238)

Real-World Evidence BRIDGE: A Tool to Connect Protocol With Code Programming [PDF]

open access: yes
OBJECTIVE: To enhance documentation on programming decisions in Real World Evidence (RWE) studies. MATERIALS AND METHODS: We analyzed several statistical analysis plans (SAP) within the Vaccine Monitoring Collaboration for Europe (VAC4EU) to identify ...
Weibel, Daniel   +7 more
core  

Molecular Characterization of Non‐Specific Esophagitis Reveals a Distinct Non‐Eosinophilic Phenotype With Fibrotic Traits

open access: yesAllergy, EarlyView.
This study comprehensively characterizes non‐specific esophagitis and elucidates eosinophil‐independent fibrosis mechanisms. NSE appears to be a distinct fibrotic phenotype of the esophagus, without any considerable overlap with GERD and other chronic inflammatory disorders such as EoE or lymphocytic esophagitis.
Marc Pfefferle   +16 more
wiley   +1 more source

Expert survey on real‐world data utilization and real‐world evidence generation for regulatory decision‐making in drug lifecycle in Korea

open access: yesClinical and Translational Science
As the importance of utilizing real‐world data (RWD)/real‐world evidence (RWE) for supporting regulatory scientific decision‐making continues to grow, experiences and inputs from experts become crucial for developing a systematic and practice‐oriented ...
Hankil Lee   +4 more
doaj   +1 more source

Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance

open access: yesJournal of Market Access & Health Policy
Background: Real-world evidence (RWE) can reinforce clinical trial evidence in health technology assessment (HTA). Objectives: Review HTA bodies’ (HTAbs) requirements for RWE, real uses, and acceptance across seven countries (Brazil, Canada, France ...
Katia Thokagevistk   +14 more
doaj   +1 more source

RWE 1

open access: yes, 2010
The World's Reactors, No. 14, RWE 1, Dettingen, near Frankfurt-Main.
Nuclear Engineering International
core  

Remission in Global Airway Diseases: EUFOREA Consensus Paper

open access: yesAllergy, EarlyView.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow   +22 more
wiley   +1 more source

PNS219 RWE ALGORITHMS - THE BUILDING BLOCKS OF RWE QUALITY [PDF]

open access: yesValue in Health, 2020
J. Murray   +3 more
openaire   +1 more source

Umweltschutz bei RWE 1996

open access: yes, 1996
Umwelt- und Ressourcenschonung sind Ziele, die in der politischen Diskussion und im Handeln der Unternehmen eine immer groessere Bedeutung gewinnen. Dies gilt uneingeschraenkt auch fuer alle Unternehmensbereiche des RWE-Konzerns -Energie, Bergbau und ...
Rheinisch-Westfaelisches Elektrizitaetswerk AG, Essen (Germany)
core  

RWE AG (Rheinisch Westfälisches Elektrizitätswerk AG)

open access: yes, 2000
Lorrain Dominique. RWE AG (Rheinisch Westfälisches Elektrizitätswerk AG). In: Flux, n°39-40, 2000. pp.
Lorrain, Dominique, Dominique Lorrain
core   +1 more source

Comparative Real‐World Effectiveness of Anti‐TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA‐IBD Registry in Germany

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
A pooled analysis from the prospective UMBRELLA‐IBD registry in Germany (n = 1567) showed comparative real‐world effectiveness in treatment persistence and clinical remission of anti‐TNF, Ustekinumab and Vedolizumab in Crohn's disease patients over 24 months.
Arne Bokemeyer   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy